Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma

Oncology Reports

Volumn 28, Issue 4, 2012, Pages 1283-1292

  Jeong, Chi Young ^a   Hah, Young Sool ^b   Cho, Bok Im ^a   Lee, Seon Min ^a   Joo, Young Tae ^a   Jung, Eun Jung ^a   Jeong, Sang Ho ^a   Lee, Young Joon ^a   Choi, Sang Kyung ^a   Ha, Woo Song ^a   Park, Soon Tae ^a   Hong, Soon Chan ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Fatty acid binding protein 5; Intrahepatic cholangiocarcinoma; Invasion; Proliferation; Proteome

Indexed keywords

FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 5; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LYMPH NODE METASTASIS; MALE; MITOSIS INHIBITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; TUMOR VASCULARIZATION; UNINDEXED SEQUENCE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; FATTY ACID-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROTEOMICS; REFERENCE VALUES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84866441579     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1922     Document Type: Article

References (31)

1. Blechacz B and Gores GJ: Cholangiocarcinoma: advances in pathogenesis, diagnosis and treatment. Hepatology 48: 308-321, 2008.
2. Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T and Makuuchi M: A new staging system for mass-forming intrahepatic cholangiocarcinoma. Cancer 92: 2374-2383, 2001.
3. Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G and Iacono C: Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 33: 1247-1254, 2009.
4. Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ and Chung JB: The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16: 3048-3056, 2009.
5. Zimmerman AW and Veerkamp JH: New insights into the structure and function of fatty acid-binding proteins. Cell Mol Life Sci 59: 1096-1116, 2002.
6. Coe NR and Bernlohr DA: Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim Biophys Acta 1391: 287-306, 1998.
7. Glatz JF and Storch J: Unravelling the significance of cellular fatty acid-binding proteins. Curr Opin Lipidol 12: 267-274, 2001.
8. Madsen P, Rasmussen HH, Leffers H, Honoré B and Celis JE: Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J Invest Dermatol 99: 299-305, 1992.
9. Haunerland NH and Spener F: Fatty acid-binding proteins - insights from genetic manipulations. Prog Lipid Res 43: 328-349, 2004.
10. Sinha P, Hütter G, Köttgen E, Dietel M, Schadendorf D and Lage H: Increased expression of epidermal fatty acid binding protein, cofilin and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis 20: 2952-2960, 1999.
11. Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H, Orntoft TF, Wolf H and Celis JE: Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res 57:4111-4117, 1997.
12. Adamson J, Morgan EA, Beesley C, Mei Y, Foster CS, Fujii H, Rudland PS, Smith PH and Ke Y: High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity. Oncogene 22: 2739-2749, 2003.
13. Xu HE, Lambert MH and Montana VG: Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3: 397-403, 1999.
14. Morgan E, Kannan-Thulasiraman P and Noy N: Involvement of fatty acid binding protein 5 and PPARβ/α in prostate cancer cell growth. PPAR Res 2010: 234629, 2010.
15. Jung EJ, Moon HG and Cho BI: Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int J Cancer 120:2331-2338, 2007.
16. Landry F, Lombardo CR and Smith JW: A method for application of samples to matrix-assisted laser desorption ionization time-of-flight targets that enhances peptide detection. Anal Biochem 279:1-8, 2000.
17. Yates JR: Database searching using mass spectrometry data. Electrophoresis 19: 893-900, 1998.
18. Hsu SM, Raine L and Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981.
19. Fang LY, Wong TY, Chiang WF and Chen YL: Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma. J Oral Pathol Med 39: 342-348, 2010.
20. Sirica AE: Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 41: 5-15, 2005.
21. Shimonishi T, Sasaki M and Nakanuma Y: Precancerous lesions of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 7: 542-550, 2000.
22. Kawase H, Fujii K, Miyamoto M, Kubota KC, Hirano S, Kondo S and Inagaki F: Differential LC-MS-based proteomics of surgical human cholangiocarcinoma tissues. J Proteome Res 8: 4092-4103, 2009.
23. Srisomsap C, Sawangareetrakul P, Subhasitanont P, Panichakul T, Keeratichamroen S, Lirdprapamongkol K, Chokchaichamnankit D, Sirisinha S and Svasti J: Proteomic analysis of cholangiocarcinoma cell line. Proteomics 4: 1135-1144, 2004.
24. Jing C, Beesley C, Foster CS, Chen H, Rudland PS, West DC, Fujii H, Smith PH and Ke Y: Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells. Cancer Res 61: 4357-4364, 2001.
25. Fujii K, Kondo T, Yokoo H, Yamada T, Iwatsuki K and Hirohashi S: Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 5: 1411-1422, 2005.
26. Glatz JFC, Schaap FG, Binas B, Bonen A, van der Vusse GJ and Luiken J: Cytoplasmic fatty acid-binding protein facilitates fatty acid utilization by skeletal muscle. Acta Physiol Scand 178: 367-371, 2003.
27. Schroeder F, Petrescu AD, Huang H, Atshaves BP, McIntosh AL, Martin GG, Hostetler HA, Vespa A, Landrock D and Landrock KK: Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids 43: 1-17, 2008.
28. Desvergne B and Wahli W: Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20:649-688, 1999.
29. Lim K, Han C, Xu L, Isse K, Demetris AJ and Wu T: Cyclooxygenase-2- derived prostaglandin E2 activates betacatenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids. Cancer Res 68: 553-560, 2008.
30. Wu T: Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma. Biochim Biophys Acta 1755: 135-150, 2005.
31. Xu L, Han C and Wu T: A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth. J Biol Chem 281: 33982-33996, 2006.